癌症
肿瘤微环境
免疫学
癌症免疫疗法
免疫疗法
背景(考古学)
癌细胞
效应器
肿瘤进展
生物
癌症研究
抗体
髓源性抑制细胞
免疫系统
医学
抑制器
内科学
古生物学
作者
Louise W. Treffers,Ida H. Hiemstra,Taco Willem Kuijpers,Timo K. van den Berg,Hanke L. Matlung
摘要
Neutrophils play an important role in cancer. This does not only relate to the well-established prognostic value of the presence of neutrophils, either in the blood or in tumor tissue, in the context of cancer progression or for the monitoring of therapy, but also to their active role in the progression of cancer. In the current review, we describe what is known in general about the role of neutrophils in cancer. What is emerging is a complex, rather heterogeneous picture with both pro- and anti-tumorigenic roles, which apparently differs with cancer type and disease stage. Furthermore, we will discuss the well-known role of neutrophils as myeloid-derived suppressor cells (MDSC), and also on the role of neutrophils as important effector cells during antibody therapy in cancer. It is clear that neutrophils contribute substantially to cancer progression in multiple ways, and this includes both direct effects on the cancer cells and indirect effect on the tumor microenvironment. While in many cases neutrophils have been shown to promote tumor progression, for instance by acting as MDSC, there are also protective effects, particularly when antibody immunotherapy is performed. A better understanding of the role of neutrophils is likely to provide opportunities for immunomodulation and for improving the treatment of cancer patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI